| NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited; and has collaboration with Elevation Oncology to expand genomic testing for NRG1 fusions across solid tumors. The company was founded in 2001 and is headquartered in Fort Myers, Florida. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Brown Douglas Matthew | Chief Strategy Officer | Nov 26 | Sale | 36.85 | 33,334 | 1,228,358 | 11,644 | Nov 26 04:14 PM | | Bonello William | President, Informatics | Nov 24 | Option Exercise | 8.03 | 25,000 | 200,750 | 40,473 | Nov 29 04:16 PM | | Bonello William | President, Informatics | Nov 24 | Sale | 37.13 | 25,000 | 928,250 | 15,473 | Nov 29 04:16 PM | | Brown Douglas Matthew | Chief Strategy Officer | Nov 24 | Sale | 36.84 | 33,333 | 1,227,988 | 44,978 | Nov 26 04:14 PM | | Brown Douglas Matthew | Chief Strategy Officer | Nov 23 | Sale | 37.19 | 33,333 | 1,239,654 | 78,311 | Nov 26 04:14 PM | | CROWTHER BRUCE K | Director | Jun 08 | Option Exercise | 14.58 | 20,734 | 302,241 | 70,298 | Jun 10 05:01 PM | | CROWTHER BRUCE K | Director | Jun 08 | Sale | 41.46 | 20,734 | 859,632 | 49,564 | Jun 10 05:01 PM | | CARDOZA GEORGE | President, Pharma Services | Jun 03 | Sale | 40.11 | 31,107 | 1,247,702 | 176,772 | Jun 04 07:56 PM | | CARDOZA GEORGE | President, Pharma Services | Jun 02 | Sale | 40.39 | 169,230 | 6,835,200 | 207,879 | Jun 04 07:56 PM | | SHOVLIN ROBERT J. | President, Clinical Services | May 25 | Option Exercise | 11.80 | 126,958 | 1,498,530 | 280,705 | May 27 06:23 PM | | SHOVLIN ROBERT J. | President, Clinical Services | May 25 | Sale | 39.31 | 130,604 | 5,134,043 | 150,101 | May 27 06:23 PM | | Weiss Lawrence Martin | Chief Medical Officer | Apr 22 | Option Exercise | 20.11 | 25,050 | 503,646 | 130,847 | Apr 26 05:48 PM | | JONES STEVEN C | Director | Jan 07 | Option Exercise | 7.15 | 100,000 | 715,000 | 1,100,000 | Jan 11 05:24 PM | | JONES STEVEN C | Director | Jan 07 | Option Exercise | 11.79 | 17,286 | 203,835 | 90,218 | Jan 11 05:24 PM | | Weiss Lawrence Martin | Chief Medical Officer | Dec 14 | Option Exercise | 9.40 | 109,004 | 1,024,986 | 120,721 | Dec 15 08:51 PM | | Weiss Lawrence Martin | Chief Medical Officer | Dec 14 | Sale | 51.06 | 20,200 | 1,031,412 | 100,521 | Dec 15 08:51 PM | | JONES STEVEN C | Director | Dec 14 | Sale | 51.67 | 25,000 | 1,291,750 | 1,000,000 | Dec 14 05:49 PM | | BALLIET JENNIFER | VP and Chief Culture Officer | Dec 11 | Option Exercise | 8.03 | 15,000 | 120,450 | 39,980 | Dec 11 05:57 PM | | BALLIET JENNIFER | VP and Chief Culture Officer | Dec 11 | Sale | 49.99 | 15,000 | 749,850 | 24,980 | Dec 11 05:57 PM | | JONES STEVEN C | Director | Dec 11 | Sale | 50.52 | 25,000 | 1,263,000 | 1,025,000 | Dec 14 05:49 PM | | JONES STEVEN C | Director | Dec 10 | Sale | 50.30 | 20,000 | 1,006,000 | 1,050,000 | Dec 14 05:49 PM | | JONES STEVEN C | Director | Dec 07 | Sale | 49.45 | 45,658 | 2,257,788 | 1,070,000 | Dec 07 06:23 PM | | Johnson Kevin C | Director | Dec 04 | Sale | 47.88 | 24,683 | 1,181,822 | 30,983 | Dec 07 06:19 PM | | JONES STEVEN C | Director | Dec 04 | Sale | 48.07 | 64,394 | 3,095,420 | 1,115,658 | Dec 07 06:23 PM | | JONES STEVEN C | Director | Dec 03 | Sale | 48.03 | 19,948 | 958,102 | 1,180,052 | Dec 07 06:23 PM | | Bonello William | President, Informatics | Dec 02 | Option Exercise | 8.03 | 8,000 | 64,240 | 20,060 | Dec 04 06:03 PM | | Bonello William | President, Informatics | Dec 02 | Sale | 46.80 | 8,000 | 374,400 | 12,060 | Dec 04 06:03 PM |
|
